India's AI potential is immense, with projections of $550 billion in economic value by 2035. Enterprises seek policy sup...
Celebrity brand endorsements saw a significant 22% decline in 2025, marking the steepest drop. Companies are shifting bu...
Indian pharma leaders are urging the government for increased research and development incentives in the upcoming Union ...
Union Budget 2026: Indian pharmaceutical and healthcare leaders are urging the government to prioritize enhanced R&D inc...
Medical inflation in India is soaring, making health insurance unaffordable and leading to higher out-of-pocket expenses...
Indian benchmark indices Sensex and Nifty have seen a significant decline of over 4% this month, driven by foreign fund ...
The clubs are both in the Championship this season but one is minted and the other is playing with a shoestring budget B...
Ahead of the Union Budget 2026, pharma players push for API self-reliance and export competitiveness.
A key shift we expect is transition in policy emphasis from stimulating consumption to enabling production, reflecting a...
The old-regime base is shrinking as more taxpayers move to the new, lower-rate, minimal exemptions regime. While many ar...